LOINC
Version 2.73

LP16236-9PemolineActive

Descriptions

LP16236-9   Pemoline
Pemoline has some advantages over other stimulants in that it does not reduce the appetite or cause dry mouth. However, in some patients Pemoline is suspected of causing liver damage, so regular liver tests are performed on those treated with it. Since receiving FDA approval in 1975, it has been linked with 21 cases of liver failure, of which 13 resulted in liver replacement or death. In 2005, the Food and Drug Administration (FDA) withdrew approval for Pemoline due to pressure from certain public advocacy groups, including Public Citizen. Patient support group the Narcolepsy Network tried to persuade the FDA not to ban it, on the grounds that some patients find all other treatments ineffective or to have dehabilitating side effects. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Pemoline (Wikipedia)

LP16236-9   Pemoline
A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children. Source: National Library of Medicine, MeSH 2006

Basic Part Properties

Name
Pemoline
Type
Component
Created On
2000-05-04
Construct for LOINC Short Name
Pemoline

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16236-9

Language Variants Get Info

zh-CNChinese (China)
苯异妥英
Synonyms: C9H8N2O2;佩默林;匹莫林;帕吗啉
nl-NLDutch (Netherlands)
pemoline
et-EEEstonian (Estonia)
Pemoliin
fr-BEFrench (Belgium)
Pémoline
fr-CAFrench (Canada)
Pémoline
it-ITItalian (Italy)
Pemolina
ru-RURussian (Russian Federation)
Пемолин
es-ESSpanish (Spain)
Pemolina
Synonyms: Cylert
tr-TRTurkish (Turkey)
Pemolin